HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

As experts in hematology HORIBA UK Ltd, Medical announces that the Company has published a white paper entitled, ‘COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients’.